Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q1

4544.TEDINET S100OZDP
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥65.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥272.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥63.5bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥8.6bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥12.2bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥8.5bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥47.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥11.9bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥8.1bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥11.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥8.3bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥278.3bnat 2022-06-30Cons.Assets
Total assets¥286.6bnat 2022-03-31Cons.Assets
Total assets¥250.2bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥132.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥146.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥146.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥140.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥118.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥39.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥46.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥39.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥37.3bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥43.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥6.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥55.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.6bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.3bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥30.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.4bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥21.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥8.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥98.252022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥519.552021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥146.32021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥98.242022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥519.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥146.232021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio52.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥607m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥27m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥15.0bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-06-30¥440m
—segment totalrevenue2022-04-01 → 2022-06-30¥68.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥65.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥9.2bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥2.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥2.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥502m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥41.7bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥41.7bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥14m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥16.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥14.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2021-04-01 → 2021-06-30¥7.4bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2021-04-01 → 2021-06-30¥7.4bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥5m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2021-04-01 → 2021-06-30¥821m
—segment totalrevenue2021-04-01 → 2021-06-30¥65.4bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥63.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥2.0bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥12.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 460
ItemContextValueUnit
Intangible assetsPrior1YearInstant34406000000JPY
Intangible assetsCurrentQuarterInstant34367000000JPY
Investment securitiesPrior1YearInstant8300000000JPY
Investment securitiesCurrentQuarterInstant8782000000JPY
Other ioaPrior1YearInstant34861000000JPY
Other ioaCurrentQuarterInstant33942000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-165000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-175000000JPY
Investments and other assetsPrior1YearInstant42996000000JPY
Investments and other assetsCurrentQuarterInstant42549000000JPY
Noncurrent assetsPrior1YearInstant153923000000JPY
Noncurrent assetsCurrentQuarterInstant155253000000JPY
Deferred assetsPrior1YearInstant121000000JPY
Deferred assetsCurrentQuarterInstant114000000JPY
AssetsPrior1YearInstant286587000000JPY
AssetsCurrentQuarterInstant278275000000JPY
Notes and accounts payable tradePrior1YearInstant21307000000JPY
Notes and accounts payable tradeCurrentQuarterInstant20905000000JPY
Electronically recorded obligations operating clPrior1YearInstant1025000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant1489000000JPY
Current portion of long term loans payablePrior1YearInstant3621000000JPY
Current portion of long term loans payableCurrentQuarterInstant5510000000JPY
Accounts payable otherPrior1YearInstant14921000000JPY
Accounts payable otherCurrentQuarterInstant13865000000JPY
Income taxes payablePrior1YearInstant5834000000JPY
Income taxes payableCurrentQuarterInstant1585000000JPY
Provision for bonusesPrior1YearInstant6870000000JPY
Provision for bonusesCurrentQuarterInstant2509000000JPY
Other clPrior1YearInstant17174000000JPY
Other clCurrentQuarterInstant14201000000JPY
Current liabilitiesPrior1YearInstant70755000000JPY
Current liabilitiesCurrentQuarterInstant60067000000JPY
Bonds payablePrior1YearInstant35000000000JPY
Bonds payableCurrentQuarterInstant35000000000JPY
Long term loans payablePrior1YearInstant18700000000JPY
Long term loans payableCurrentQuarterInstant15000000000JPY
Net defined benefit liabilityPrior1YearInstant5470000000JPY
Net defined benefit liabilityCurrentQuarterInstant5562000000JPY
Asset retirement obligations nclPrior1YearInstant1046000000JPY
Asset retirement obligations nclCurrentQuarterInstant1205000000JPY
Provision for share based remuneration nclPrior1YearInstant572000000JPY
Provision for share based remuneration nclCurrentQuarterInstant630000000JPY
Provision for compensation loss nclPrior1YearInstant709000000JPY
Provision for compensation loss nclCurrentQuarterInstant851000000JPY
Provision for loss on guaranteesPrior1YearInstant1414000000JPY
Provision for loss on guaranteesCurrentQuarterInstant1236000000JPY
Other nclPrior1YearInstant12739000000JPY
Other nclCurrentQuarterInstant12718000000JPY
Noncurrent liabilitiesPrior1YearInstant75653000000JPY
Noncurrent liabilitiesCurrentQuarterInstant72205000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass